Comparative Outcomes of Standard Perioperative Eye Drops, Intravitreal Triamcinolone Acetonide-Moxifloxacin, and Intracameral Dexamethasone-Moxifloxacin-Ketorolac in Cataract Surgery
Background. Since the advent of cataract surgery, topical eye drops have been the mainstay of postoperative prophylaxis and treatment. Due to factors such as high expenses and poor patient compliance, there has been a growing interest and acceptance of “dropless” or “less drops” alternatives. The pu...
Saved in:
Main Authors: | Robin K. Kuriakose, Soungmin Cho, Saman Nassiri, Frank S. Hwang |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-01-01
|
Series: | Journal of Ophthalmology |
Online Access: | http://dx.doi.org/10.1155/2022/4857696 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Toxic Anterior Segment Syndrome with Intracameral Moxifloxacin: Case Report and Review of the Literature
by: Annahita Amireskandari, et al.
Published: (2021-01-01) -
Suprachoroidal Versus Intravitreal Injection of Triamcinolone Acetonide As Primary Treatment For Diabetic Macular Edema
by: Fatima Shafqat Khan, et al.
Published: (2023-12-01) -
Adjunct Intravitreous Triamcinolone Acetonide in the Treatment of Diabetic Macular Edema with Anti-VEGF Agents
by: Robert B. Garoon, et al.
Published: (2016-01-01) -
The Anterior Chamber Injection of Moxifloxacin Injection to Prevent Endophthalmitis after Cataract Surgery: A Meta-analysis
by: Xiao-lei Wang, et al.
Published: (2020-01-01) -
Clinical Comparative Study of Intravitreal Injection of Triamcinolone Acetonide and Aflibercept in the Treatment of Diabetic Retinopathy Cystoid Macular Edema
by: Yanxia Zhu, et al.
Published: (2022-01-01)